Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051217814> ?p ?o ?g. }
- W2051217814 endingPage "2013" @default.
- W2051217814 startingPage "2013" @default.
- W2051217814 abstract "The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells Junxia Zhang,1,* Qiang Zhou,2,* Ge Gao,3,* Yanfen Wang,1 Zhihui Fang,1 Guanlin Li,4 Mengfei Yu,5 Lingfei Kong,6 Ying Xing,3 Xiaoqun Gao11Department of Anatomy, Basic Medical College, Zhengzhou University, Henan, People’s Republic of China; 2Department of Pathology, Children’s Hospital of Zhengzhou City, Henan, People’s Republic of China; 3Department of Physiology, Basic Medical College, Zhengzhou University, Henan, People’s Republic of China; 4Department of Laboratory, The First Affiliated Hospital of Zhengzhou University, Henan, People’s Republic of China; 5Department of Pharmacy, Zhengzhou Central Hospital, Zhengzhou University, Henan, People’s Republic of China; 6Department of Pathology, Henan Provincial People’s Hospital, Henan, People’s Republic of China *These authors contributed equally to this workAbstract: Glioblastoma is one of the most common malignant tumors in the nervous system in both adult and pediatric patients. Studies suggest that abnormal activation of receptor tyrosine kinases contributes to pathological development of glioblastoma. However, current therapies targeting tyrosine kinase receptors have poor therapeutic outcomes. Here, we examined anticancer effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, on glioblastoma cells both in the U87MG cell line and in the mouse xenograft model. We showed that ponatinib treatment reduced cell viability and induced cell apoptosis in a dose-dependent manner in U87MG cells. In addition, ponatinib suppressed migration and invasion of U87MG cells effectively. Furthermore, ponatinib-treated tumors showed an obvious reduction of tumor volume and an increase of apoptosis as compared with vehicle-treated tumors in the mouse xenograft model. These findings support a potential application of ponatinib as a chemotherapeutic option against glioblastoma cells.Keywords: cancer therapy, glioma, glioblastoma multiforme" @default.
- W2051217814 created "2016-06-24" @default.
- W2051217814 creator A5007197560 @default.
- W2051217814 creator A5013090158 @default.
- W2051217814 creator A5023023072 @default.
- W2051217814 creator A5044188620 @default.
- W2051217814 creator A5052327187 @default.
- W2051217814 creator A5055694167 @default.
- W2051217814 creator A5072673471 @default.
- W2051217814 creator A5076767097 @default.
- W2051217814 creator A5078687129 @default.
- W2051217814 creator A5085927434 @default.
- W2051217814 date "2014-10-01" @default.
- W2051217814 modified "2023-09-26" @default.
- W2051217814 title "The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells" @default.
- W2051217814 cites W1588322702 @default.
- W2051217814 cites W164445532 @default.
- W2051217814 cites W1837740082 @default.
- W2051217814 cites W1963558982 @default.
- W2051217814 cites W1985573533 @default.
- W2051217814 cites W1985772559 @default.
- W2051217814 cites W2001666227 @default.
- W2051217814 cites W2013959979 @default.
- W2051217814 cites W2014994637 @default.
- W2051217814 cites W2016569044 @default.
- W2051217814 cites W2023563217 @default.
- W2051217814 cites W2032344621 @default.
- W2051217814 cites W2049884365 @default.
- W2051217814 cites W2059890247 @default.
- W2051217814 cites W2061760261 @default.
- W2051217814 cites W2065319085 @default.
- W2051217814 cites W2070287558 @default.
- W2051217814 cites W2076168158 @default.
- W2051217814 cites W2081978376 @default.
- W2051217814 cites W2102002182 @default.
- W2051217814 cites W2104983860 @default.
- W2051217814 cites W2106161829 @default.
- W2051217814 cites W2107731988 @default.
- W2051217814 cites W2109242805 @default.
- W2051217814 cites W2110648386 @default.
- W2051217814 cites W2121170253 @default.
- W2051217814 cites W2133037949 @default.
- W2051217814 cites W2139548754 @default.
- W2051217814 cites W2140375000 @default.
- W2051217814 cites W2141846819 @default.
- W2051217814 cites W2143897427 @default.
- W2051217814 cites W2150638747 @default.
- W2051217814 cites W2151335185 @default.
- W2051217814 cites W2160511594 @default.
- W2051217814 cites W2161289668 @default.
- W2051217814 cites W2167719636 @default.
- W2051217814 cites W2322137434 @default.
- W2051217814 cites W85529956 @default.
- W2051217814 doi "https://doi.org/10.2147/ott.s67556" @default.
- W2051217814 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4218911" @default.
- W2051217814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25378936" @default.
- W2051217814 hasPublicationYear "2014" @default.
- W2051217814 type Work @default.
- W2051217814 sameAs 2051217814 @default.
- W2051217814 citedByCount "15" @default.
- W2051217814 countsByYear W20512178142015 @default.
- W2051217814 countsByYear W20512178142016 @default.
- W2051217814 countsByYear W20512178142017 @default.
- W2051217814 countsByYear W20512178142018 @default.
- W2051217814 countsByYear W20512178142019 @default.
- W2051217814 countsByYear W20512178142020 @default.
- W2051217814 countsByYear W20512178142021 @default.
- W2051217814 countsByYear W20512178142023 @default.
- W2051217814 crossrefType "journal-article" @default.
- W2051217814 hasAuthorship W2051217814A5007197560 @default.
- W2051217814 hasAuthorship W2051217814A5013090158 @default.
- W2051217814 hasAuthorship W2051217814A5023023072 @default.
- W2051217814 hasAuthorship W2051217814A5044188620 @default.
- W2051217814 hasAuthorship W2051217814A5052327187 @default.
- W2051217814 hasAuthorship W2051217814A5055694167 @default.
- W2051217814 hasAuthorship W2051217814A5072673471 @default.
- W2051217814 hasAuthorship W2051217814A5076767097 @default.
- W2051217814 hasAuthorship W2051217814A5078687129 @default.
- W2051217814 hasAuthorship W2051217814A5085927434 @default.
- W2051217814 hasBestOaLocation W20512178141 @default.
- W2051217814 hasConcept C101544691 @default.
- W2051217814 hasConcept C121608353 @default.
- W2051217814 hasConcept C126322002 @default.
- W2051217814 hasConcept C143998085 @default.
- W2051217814 hasConcept C170493617 @default.
- W2051217814 hasConcept C2778820342 @default.
- W2051217814 hasConcept C2779536868 @default.
- W2051217814 hasConcept C2780381907 @default.
- W2051217814 hasConcept C42362537 @default.
- W2051217814 hasConcept C502942594 @default.
- W2051217814 hasConcept C556039675 @default.
- W2051217814 hasConcept C71924100 @default.
- W2051217814 hasConceptScore W2051217814C101544691 @default.
- W2051217814 hasConceptScore W2051217814C121608353 @default.
- W2051217814 hasConceptScore W2051217814C126322002 @default.
- W2051217814 hasConceptScore W2051217814C143998085 @default.
- W2051217814 hasConceptScore W2051217814C170493617 @default.
- W2051217814 hasConceptScore W2051217814C2778820342 @default.